Cargando…

Effect of polypharmacy on plasma bepridil concentration in patients with heart failure: a multicenter retrospective study

BACKGROUND: Polypharmacy, defined as the concurrent use of over six drugs, is common in the treatment of heart failure (HF); however, unpredictable drug interactions with bepridil may occur. In this study, we have elucidated the influence of polypharmacy on plasma bepridil concentrations in patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asai, Yuki, Arihara, Hiroki, Omote, Saki, Tanio, Ena, Yamashita, Saena, Higuchi, Takashi, Hashimoto, Ei, Yamada, Momoko, Tsuji, Hinako, Kondo, Yoshihiro, Hayashi, Makoto, Yamamoto, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9987070/ https://www.ncbi.nlm.nih.gov/pubmed/36872399 http://dx.doi.org/10.1186/s40780-023-00278-x

Ejemplares similares

Effects of bepridil on early cardiac development of zebrafish
por: Wei, Ya-Lan, et al.
Publicado: (2022)

Bepridil monotherapy failed to prevent coronary vasospasm in a Brugada syndrome patient
por: Kazatani, Takuro, et al.
Publicado: (2022)

Bepridil is potent against SARS-CoV-2 In Vitro
por: Vatansever, Erol C., et al.
Publicado: (2020)

Bepridil is potent against SARS-CoV-2 in vitro
por: Vatansever, Erol C., et al.
Publicado: (2021)

Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation
por: Yakabe, Daisuke, et al.
Publicado: (2021)

Successful treatment of bepridil-induced intraoperative torsades de pointes by isoproterenol infusion
por: Shimano, Ken, et al.
Publicado: (2021)

Suppression of Metastatic Ovarian Cancer Cells by Bepridil, a Calcium Channel Blocker
por: Zhang, Songzi, et al.
Publicado: (2023)

3-Chlorodiphenylamine activates cardiac troponin by a mechanism distinct from bepridil or TFP
por: Tikunova, Svetlana B., et al.
Publicado: (2019)

Bepridil, a class IV antiarrhythmic agent, can block the TREK-1 potassium channel
por: Wang, Ying, et al.
Publicado: (2021)

Bepridil Might be Potent Against the Coronavirus Disease 2019–related Electrical Storm in Brugada Syndrome
por: Higaki, Akinori
Publicado: (2022)

Bepridil decreases Aβ and calcium levels in the thalamus after middle cerebral artery occlusion in rats
por: Sarajärvi, Timo, et al.
Publicado: (2012)

Bepridil exhibits anti‐leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia
por: Baldoni, Stefano, et al.
Publicado: (2018)

Non-Selective Calcium Channel Blocker Bepridil Decreases Secondary Pathology in Mice after Photothrombotic Cortical Lesion
por: Lipsanen, Anu, et al.
Publicado: (2013)

Effectiveness of countermeasure for polypharmacy by multidisciplinary team review in patients with diabetes mellitus
por: Nishida, Shohei, et al.
Publicado: (2023)

Polypharmacy Is Associated With Amiodarone-Induced Hypothyroidism
por: Yokoyama, Satoshi, et al.
Publicado: (2021)

Polypharmacy in the elderly
por: Golchin, Negar, et al.
Publicado: (2015)

Antipsychotic polypharmacy reduction versus polypharmacy continuation for people with schizophrenia
por: Bighelli, Irene, et al.
Publicado: (2022)

The Relationship Between Polypharmacy and Hospital-stay Duration: A Retrospective Study
por: Fukuba, Nobuhiko, et al.
Publicado: (2020)

Multimorbidity, polypharmacy, and mortality in older patients with pacemakers
por: Goto, Toshihiko, et al.
Publicado: (2021)

Validation of the three-chamber strategy for studying mate choice in medaka
por: Kaneko, Ena, et al.
Publicado: (2021)

Are the kind of medications and patient's background associated with improving polypharmacy in elderly?
por: Tomita, Shiori, et al.
Publicado: (2018)

Polypharmacy: Misleading, but manageable
por: Bushardt, Reamer L, et al.
Publicado: (2008)

Polypharmacy among the Elderly
por: Hosseini, Seyed Reza, et al.
Publicado: (2018)

Polypharmacy in Zoological Medicine
por: Hunter, Robert P., et al.
Publicado: (2017)

Polypharmacy in the Homebound Population
por: Cook, Erin Atkinson, et al.
Publicado: (2022)

POLYPHARMACY IN ASSISTED LIVING
por: Galik, Elizabeth
Publicado: (2022)

Distinct B subunits of PP2A regulate the NF‐κB signalling pathway through dephosphorylation of IKKβ, IκBα and RelA
por: Tsuchiya, Yoshihiro, et al.
Publicado: (2017)

Trimeric structure and conformational equilibrium of M-ficolin fibrinogen-like domain
por: Tanio, Michikazu, et al.
Publicado: (2008)

Prognostic impact of polypharmacy by drug essentiality in patients on hemodialysis
por: Kitamura, Mineaki, et al.
Publicado: (2021)

Polypharmacy and Its Association with Dysphagia and Malnutrition among Stroke Patients with Sarcopenia
por: Matsumoto, Ayaka, et al.
Publicado: (2022)

Impact of Polypharmacy on the Rehabilitation Outcome of Japanese Stroke Patients in the Convalescent Rehabilitation Ward
por: Kose, Eiji, et al.
Publicado: (2016)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

Polypharmacy In Psychiatry: A Review
por: Kukreja, Sanjay, et al.
Publicado: (2013)

Polypharmacy: The past, present and the future
por: Kaur, Ginpreet
Publicado: (2013)

Heart Failure Research and Polypharmacy
por: Somberg, John
Publicado: (2022)

An Atypical Case of Extreme Polypharmacy
por: Veronin, Michael A
Publicado: (2022)

White Esophagus: The Result of Polypharmacy
por: Andres, Brendan, et al.
Publicado: (2023)

Polypharmacy and relapse of schizophrenia: are they related?
por: Softic, R., et al.
Publicado: (2022)

Efficacy of surgical treatment on polypharmacy of elderly patients with lumbar spinal canal stenosis: retrospective exploratory research
por: Nagai, Sota, et al.
Publicado: (2023)

Effectiveness in Switching from Antipsychotic Polypharmacy to Monotherapy in Patients with Schizophrenia: A Case Series
por: Kamei, Hiroyuki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jo6fqc6hihgap7341c3kp12qgu